> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Quantitative Medicine CoE Progress Update
- URL: https://www.fdaweb.com/quantitative-medicine-coe-progress-update/
- Published: 2025-09-30T12:00:00.000Z
- Updated: 2026-09-14T15:23:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5159959

In the 16 months since its founding, the CDER Quantitative Medicine Center of Excellence (QM CoE) says it has achieved “significant accomplishments” in three strategic areas — enterprise planning and coordination, applied regulatory science, and education and ecosystem development. A QM CoE [Progress and Priorities Update](https://content.govdelivery.com/accounts/USFDA/bulletins/3f50892?ref=fdaweb.com) says the Center of Excellence is a “cooperative, coordinating body that drives innovation and fosters integration of quantitative medicine approaches to advance therapeutic medical product development, inform regulatory decision-making, and promote public health.”

QM CoE director **Raj Madabushi** says that in an era of unprecedented scientific and technological advances that converge data, analytics, and medicine, the CoE approaches are “primed to play a transformative role in advancing medical product development and informing regulatory evaluation.”